ASBP
Aspire Biopharma·NASDAQ
--
--(--)
--
--(--)
ASBP Filings
Filing Date
Form Description
Form Type
2026-02-06
Form 8-K - Current report
Key Events
2026-02-06 · Key Events
Form 8-K - Current report
2026-01-30
Form 8-K - Current report
Key Events
2026-01-30 · Key Events
Form 8-K - Current report
2026-01-15
Form 8-K - Current report
Key Events
2026-01-15 · Key Events
Form 8-K - Current report
2026-01-13
Form 8-K - Current report
Key Events
2026-01-13 · Key Events
Form 8-K - Current report
2026-01-06
Form 8-K - Current report
Key Events
2026-01-06 · Key Events
Form 8-K - Current report
2025-12-15
Form EFFECT - Notice of Effectiveness
2025-12-15 ·
Form EFFECT - Notice of Effectiveness
2025-12-03
Form S-1 - General form for registration of securities under the Securities Act of 1933
2025-12-03 ·
Form S-1 - General form for registration of securities under the Securities Act of 1933
2025-11-14
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Financials
2025-11-14 · Financials
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2025-11-14
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-14 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-14
Form 8-K - Current report
Key Events
2025-11-14 · Key Events
Form 8-K - Current report
